Moderna Announces First Participant Dosed in a Phase 1 Trial of its Nipah Virus mRNA Vaccine, mRNA-1215Accesswire • 07/12/22
New omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5Market Watch • 07/11/22
Moderna says one of its COVID-19 booster candidates better protects against BA.4 and BA.5Market Watch • 07/11/22
Moderna's Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared To Currently Authorized BoosterAccesswire • 07/11/22
Why Pfizer and Moderna Would Profit As CDC Recommends Covid Vaccine For ToddlersThe Dog of Wall Street • 06/25/22
CDC panel backs Moderna vaccine for children aged 6 to 17, and study finds vaccines saved about 20 million lives in their first yearMarket Watch • 06/24/22
COVID cases surge again in Europe and Moderna says booster candidate protects against BA.4 and BA.5 omicron subvariantsMarket Watch • 06/22/22